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        Postfetal B cell development initiates in the BM 
from a common lymphoid progenitor and pro-
gresses via sequential developmental stages to 
generate immature B cells that express a func-
tional B cell receptor (BCR). Immature B cells 
subsequently migrate through the bloodstream to 
the spleen, where progression through   “  transi-
tional  ”   developmental stages is required to form 
naive mature B cells capable of diff  erentiating 
into antibody-secreting cells upon encounter 
with cognate antigen (  1  ). 
  Developing B cells are fi  rst tested for self-tol-
erance in the BM after expression of the newly 
arranged BCR on the cell surface. Cells that 
encounter self-antigen are either deleted, undergo 
receptor editing, or become anergic, depending 
on the affi   nity and the physical form of the anti-
gen encountered (  2, 3  ). Despite these events, a 
signifi  cant number of newly formed, self-reactive 
B cells survive to enter the periphery, suggesting 
that additional tolerance checkpoints must operate 
during splenic transitional B cell development. 
In humans, the relative number of self-reactive 
B cells decreases from     40 to 20% as newly 
formed immature B cells transition into the na-
ive mature B cell compartment (  4  ). This pro-
gressive decline in self-reactive cells fails to occur 
in patients with systemic lupus erythematosus or 
rheumatoid arthritis, supporting the conclusion 
that peripheral selection is essential for maintain-
ing B cell self-tolerance (  5, 6  ). Consistent with 
these observations, transgenic studies have also 
shown that if self-antigen expression is limited 
to the periphery, tolerance of self-reactive mouse 
B cells occurs primarily within the transitional 
compartment (  7, 8  ). 
  In addition to negative selection, several 
lines of evidence suggest that positive selection 
may also play an important role in shaping the 
naive mature B cell repertoire. Studies compar-
ing the BCR repertoire in BM versus periph-
eral B cells have shown diff  erences in V-gene 
usage and a bias toward specifi  c light chain/
heavy chain combinations, suggesting selection 
for certain BCRs (  9, 10  ). In circumstances where 
self-antigen is expressed at very low levels or in 
which BCR signaling is reduced, B cells that 
recognize self-antigen can exhibit a selective 
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  We have characterized a distinct, late transitional B cell subset, CD21  int   transitional 2 (T2) 
B cells. In contrast to early transitional B cells, CD21  int   T2 B cells exhibit augmented re-
sponses to a range of potential microenvironmental stimuli. Adoptive transfer studies 
demonstrate that this subset is an immediate precursor of both follicular mature and 
marginal zone (MZ) B cells. In vivo, a large percentage of CD21  int   T2 B cells has entered the 
cell cycle, and the cycling subpopulation exhibits further augmentation in mitogenic re-
sponses and B cell-activating factor of the TNF family (BAFF) receptor expression. Consis-
tent with these features, CD21  int   T2 cells exhibit preferential responses to BAFF-facilitated 
homeostatic signals in vivo. In addition, we demonstrate that M167 B cell receptor (BCR) 
idiotypic-specifi  c B cells are fi  rst selected within the cycling CD21  int   T2 population, ulti-
mately leading to preferential enrichment of these cells within the MZ B cell compartment. 
These data, in association with the coordinate role for BAFF and microenvironmental cues 
in determining the mature BCR repertoire, imply that this subset functions as a unique 
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  As shown in   Fig. 1 A  , CD24  hi   B cells can be subdivided by 
CD21 expression into CD21  lo   (which are labeled T1 B cells 
according to the Loder classifi  cation [  19  ]), CD21  int   (hence-
forth labeled CD21  int   T2 B cells), and CD21  hi   B cells.   CD21  lo   
T1 B cells can be further divided into CD23  lo   and CD23  hi   
subsets (which largely correspond to the T1 and T2 subsets 
described by Allman et al. [  23  ]) and are hereafter referred to 
as CD23  lo   T1 and CD23  hi   T1 B cells. CD21  int   cells are largely 
CD23  hi  , whereas CD21  hi   cells contain CD23  hi   T2-MZP and 
CD23  lo   MZ B cells. Follicular mature (FM) B cells express 
intermediate levels of both CD24 and CD21. The CD21  int   
T2 cells comprise 1  –  2% of total splenocytes from 8  –  12-wk-old 
mice (  Fig. 1 B  ), and using 8-color fl  ow cytometry we de-
termined that they express high levels of IgM, IgD, AA4.1, 
CD23, and CD62L and intermediate-to-low levels of LFA-1 
and CD1d (  Fig. 1 C   and Table S1, available at http://www
.jem.org/cgi/content/full/jem.20071088/DC1). These com-
bined phenotypic features are consistent with classifi  cation as 
a late transitional population. As an alternative measure of cell 
maturity, we evaluated relative GFP expression in Rag2p-GFP 
transgenic mice (  24  ). In this model, Rag2 expression terminates 
at the immature BM B cell stage and GFP expression within 
the spleen is restricted to newly formed immature B cells 
(  25  ). Analysis of GFP expression indicated that CD21  int   T2 B 
cells, like T1 cells, express high levels of GFP in contrast to the 
GFP        T2-MZP, MZ, and FM B cells (  Fig. 1 D  ). Interestingly, 
a small percentage of CD21  int   T2 B cells were GFP       ; the sig-
nifi  cance of this fi  nding will be discussed in detail below. 
  Notch signaling has been shown to play a crucial role in 
the development of T2-MZP and MZ B cells (  21  ). To fur-
ther delineate CD21  int   T2 B cells from CD21  hi   T2-MZP and 
MZ B cells, we determined relative expression of the Notch 
target genes   hes1   and   deltex1  . As previously shown (  21  ), Hes1 
and Deltex1 expression was increased three- to fi  vefold in 
T2-MZP and MZ relative to T1, CD21  int   T2, or FM B cells 
(  Fig. 1 E  ). In addition, Notch2 haplodefi  cient mice exhibited 
no reduction in CD21  int   T2 B cells, whereas T2-MZP and 
MZ numbers were reduced by 40  –  60% (unpublished data), 
indicating that Notch signaling is not essential for CD21  int   T2 
B cell development. 
  We next determined the in vitro functional responses of 
CD21  int   T2 B cells to Toll-like receptor (TLR) or BCR liga-
tion (  Fig. 2 A  ).   CD21  int   T2 B cells proliferated robustly in 
response to LPS stimulation, similar to T2-MZP or MZ B 
cells. This response was signifi  cantly greater than in either T1 
or FM B cells. BCR engagement led to a partial proliferative 
response in CD21  int   T2 B cells, in contrast to T1 B cells. To 
further characterize this response, sorted cells were labeled 
with CFSE and cell division and survival were evaluated. After 
48 h, although only a limited number of CD21  int   T2 B cells 
survived, this population exhibited a rate of cell division that 
paralleled the response of FM B cells (  Fig. 2 B  ). In contrast, no 
T1 cells survived BCR cross-linking. To exclude contamination 
with FM as the source of proliferating cells within CD21  int   
T2 cells, we performed parallel assays using mixtures of 90  –  95% 
T1 and 5  –  10% FM B cells (to mimic the maximal level of FM 
advantage (  11, 12  ). Similarly, transgenic B cell development 
arrests at the transitional B cell stage in the absence of ligand, 
and can be rescued either by BCR stimulation or adoptive 
cell transfer into lymphopenic hosts that express the relevant 
cognate self-antigen (  13  ). Finally, antigen selection is also ev-
ident within the marginal zone (MZ) compartment, where 
self-reactive transgenic B cells are specifi  cally enriched within 
the mature MZ B cell population (  14  ). 
  Although BCR specifi  city is important in determining 
whether an individual B cell survives the transitional   “  bottle-
neck,  ”   responses to key environmental signals also signifi  -
cantly contribute to determining B cell fate. In particular, B 
cell  –  activating factor of the TNF family (BAFF) appears to 
play a critical role in peripheral B cell tolerance. This prosur-
vival cytokine is necessary for B cell survival and diff  erentia-
tion beyond the late transitional stage, which is when BAFF 
receptor (BAFF-R) surface expression reaches a threshold 
level (  15, 16  ). Competition for limiting levels of BAFF has 
been hypothesized to favor self-tolerant B cells during pe-
ripheral B cell development (  17, 18  ). Consistent with this 
idea, BAFF overexpression expands both the late transitional 
and mature peripheral B cell compartments and promotes B 
cell  –  mediated autoimmunity, in part, through enhanced sur-
vival of low-affi   nity self-reactive B cells. 
  Despite mounting evidence that environmental cues sig-
nifi  cantly impact the mature BCR repertoire, studies to date 
have failed to identify a transitional subset capable of com-
petitive expansion in response to such signals. In this study, 
we have sought to directly address this issue. We have char-
acterized a bipotent, nonquiescent, phenotypically and func-
tionally distinct, late transitional B cell subset that is uniquely 
sensitive to mitogenic and homeostatic signals. Further, our 
data indicate that self-reactive B cells within this subset can 
be selectively expanded. Our combined fi  ndings indicate that 
these transitional precursors function as a sensitive cellular 
pool capable of responding to changing environmental stim-
uli, and can thereby operate as a key checkpoint in peripheral 
B cell tolerance. 
    RESULTS   
  CD21  int   transitional 2 (T2) B cells comprise a distinct 
B cell subset 
  The precise sequence of diff  erentiation of late splenic transi-
tional B cells remains incompletely defi  ned. Investigation 
from our own and other laboratories has suggested that the 
T2 B cell subset (CD21  hi/int  IgM  hi  IgD  hi  CD24  hi  ) as originally 
defi  ned by Loder et al. (  19  ) represents a heterogeneous popu-
lation. Pillai fi  rst introduced the idea of further delineating 
this population based on the relative expression of CD21 into 
T2-follicular precursor (CD21  int  ) and T2-MZ precursor (T2-
MZP; CD21  hi  ) subsets (  20  ). Although the properties of CD21  hi   
T2 B cells have become relatively well defi  ned (  20  –  22  ), little 
experimental data exists in regard to the functional properties 
and potential developmental capacity of CD21  int   transitional 
B cells. We therefore initiated studies to defi  ne the properties 
of this B cell subpopulation in greater detail. JEM VOL. 205, January 21, 2008 
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CD21  int   T2 B cells as immature splenic B cells. They are dis-
tinct from T1 B cells based on IgD, CD62L, and LFA-1 ex-
pression; increased resistance to BCR-induced cell death; 
and robust proliferation to TLR signaling. Finally, in contrast 
to CD24  hi  CD21  hi   T2-MZP and MZ B cells, CD21  int   T2 B 
cells exhibit no evidence for increased Notch signals. 
  CD21  int   T2 B cells develop after T1 B cells 
  The slightly lower expression of both GFP and AA4.1 in 
CD21  int   T2 versus T1 B cells suggested that CD21  int   T2 B 
cells were derived from T1 cells. To test this idea, we evaluated 
peripheral B cell reconstitution after sublethal irradiation. 
Adult C57BL/6 mice were irradiated with 500 cGy and 
potentially present within the sorted CD21  int   T2 population; 
Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20071088/DC1) and observed no proliferation (  Fig. 2 B  ). 
  To directly evaluate proapoptotic signaling, we measured 
BCR-induced activation of caspase 3. Although T1 cells ex-
hibited a rapid increase in active caspase 3, this response was 
markedly blunted in CD21  int   T2 B cells, similar to that in FM 
B cells. This reduction in caspase activity correlated with in-
creased survival relative to T1 B cells with and without BCR 
engagement (  Fig. 2, C and D  ). 
  In summary, CD21  int   T2 B cells represent a phenotypi-
cally and functionally distinct transitional population. High 
expression of GFP, AA4.1, and CD24 clearly characterize 
    Figure 1.     Characterization of CD21  int   T2 B cells.   (A  –  C) Expression of surface markers on splenic B cell subsets. (A) B220  + /CD19 +   splenic B cell sub-
sets gated based on CD21 and CD24. (B) Percentage and absolute number of CD21  int  T2 cells within total splenic lymphocytes in 8  –  12-wk-old C57BL/6 
mice (mean of 3 independent experiments). (C) Expression of IgM, IgD, CD62L, AA4.1, CD23, and CD1d in splenic B cell subsets. Representative of more 
than fi  ve independent experiments. (D) GFP expression in splenic B cell subsets from an 8-wk-old Rag2p-GFP transgenic mouse. (E) Expression of Notch 
target genes. Relative Hes1 and Deltex1 expression are shown as fold change of each subset relative to FM B cells set as 1. Data represented as the mean 
with SD from four independent experiments.     158 HOMEOSTATIC PROLIFERATION IN TRANSITIONAL B CELLS | Meyer-Bahlburg et al.
    Figure 2.     CD21  int   T2 B cells are functionally distinct.   (A) Proliferative responses of purifi  ed B cell subsets after incubation for 48 h in media alone, 
with anti-IgM or LPS. (B) CFSE-labeled B cell subsets were cultured in media alone (dashed lines) or with anti-IgM (solid lines) for 48 h, and proliferation 
was analyzed by dilution of CFSE. Numbers indicate the percentage of live cells in unstimulated versus anti-IgM  –  stimulated (bold) cultures. T1 cells did 
not survive anti-IgM stimulation, so no trace is shown. (C) Sorted cells were cultured with anti-IgM and apoptosis measured by caspase 3 activity at indi-
cated time points. Numbers indicate the percentage of active caspase 3  +   cells within the live lymphocyte gate. (D) Kinetic analysis of caspase 3 activity 
and cell survival. (top) The percentage of active caspase 3  +   cells from the experiment shown in C. (bottom) The percentage of live cells, based on 7-AAD 
staining over time with or without BCR engagement. Data are representative of at least three independent experiments.     
  splenocytes analyzed on day 11, 13, 15, 17, and 19 after irradia-
tion (  Fig. 3  ).   Whereas T1 B cells peaked on day 13, the number 
of CD21  int   T2 B cells was maximal on day 15  –  17 and decreased 
markedly by day 19. In contrast, the number of FM B cells 
progressively increased between day 13 and 17, and they 
comprised the majority of cells by day 17  –  19. Smaller num-
bers of CD21  hi   T2-MZP and MZ B cells could be identifi  ed 
beginning at day 17. A similar progression in B cell subset 
development was seen via analysis of splenic B cell subsets in 
unmanipulated neonates at various ages (unpublished data). 
  CD21  int   T2 B cells comprise a bipotent precursor for FM 
and MZ B cells 
  To directly analyze the developmental capacity of CD21  int   T2 
B cells, we performed adoptive cell transfer experiments. To 
obtain suffi   cient numbers of this relatively rare population, CD-
24  hi  CD21  int  IgM  hi   B cells were purifi  ed from sublethally irra-
diated mice (day 15). Postsort purities were consistently   >  90%, 
with   <  0.2% contaminating T2-MZP/MZ and   <  1.5% FM 
B cells. Though more contaminating T1 cells were present, 
these should not alter our experimental interpretation, as they 
comprise precursors for CD21  int   T2 B cells. Sorted populations 
exhibited the features of CD21  int   T2 cells based on phenotypic 
markers, relative Deltex1 and Cyclin D2 mRNA expression, 
and BCR and TLR responses (Fig. S2, A-E, available at http://
www.jem.org/cgi/content/full/jem.20071088/DC1). 
  Purifi  ed Ly5.1  +   CD21  int   T2 B cells were labeled with CFSE 
and injected into nonlymphopenic, adult Ly5.2  +   C57BL/6 
mice. Similar to previously published results (  22  ), recovery of 
transferred cells was 1  –  1.5%. Even as early as day 1, transferred 
CD21  int   T2 B cells developed into both FM (CD24  int  CD21  int-
  IgM  lo  CD1d  lo  ) and T2-MZP/MZ (CD24  hi  CD21  hi  IgM  hi  CD1d  hi  ) 
B cells (  Fig. 4  ). We conclude from these data that the CD21  int   
T2 subset contains immediate precursors for both FM and 
T2-MZP/MZ B cells.   
  CD21  int   T2 B cells cycle in vivo 
  We observed a signifi  cant number of larger cells within the 
CD21  int   T2 cell population in contrast to either T1 or FM B 
cells (Fig. S3 A, available at http://www.jem.org/cgi/content/JEM VOL. 205, January 21, 2008 
ARTICLE
159
  We compared the functional activity and phenotype of 
quiescent versus active (G1, S, or G2) CD21  int   T2 cells. Al-
though the majority of transgenic CD21  int   T2 B cells were 
GFP  +  , a limited subpopulation was GFP        (    25  –  35%;   Fig. 1 D  ). 
As GFP is no longer transcribed, cell division was antici-
pated to dilute out the GFP signal in this subset. Thus, we 
evaluated the percentage of GFP  +   versus GFP        CD21  int   T2 
cells that had progressed beyond G0, and we observed an ap-
proximately twofold increase within the GFP        subset (  Fig. 6, 
A and B  ).   The surface phenotype of resting versus cycling cells, 
however, remained indistinguishable, indicating that these 
populations represented nearly identical stages in development 
(Fig. S4, available at http://www.jem.org/cgi/content/full/
jem.20071088/DC1). Strikingly, GFP        CD21  int   T2 B cells 
exhibited a signifi  cant enhancement in their response to BCR 
engagement, mainly through increased survival, yet retained 
full/jem.20071088/DC1), suggesting that they were more 
activated. To address this possibility, we stained splenic B cell 
populations immediately ex vivo using Pyronin Y and DAPI 
to measure RNA and DNA content, respectively, thereby 
allowing us to determine the percentage of cells in each phase 
of the cell cycle (Fig. S3 B) (  26  ). Cell doublets were carefully 
excluded before cell-cycle analysis based on DAPI width 
and area. Although on average,   >  85% of  T1 and FM B cells were 
in G0,     50% of CD21  int   T2 cells were in G1, and     5% of 
CD21  int   T2 cells had further progressed into S and G2 
phases (  Fig. 5 A  ).   
  These data strongly suggested that splenic CD21  int   T2 
cells were proliferating in vivo. To directly test this idea, we 
performed in vivo BrdU-labeling experiments. We tested the 
prediction that, at early time points, BrdU incorporation 
would be signifi  cantly higher in CD21  int   T2 cells compared 
with T1 B cells. At later times, we also predicted that (after 
the infl  ux of newly formed BrdU-labeled cells from the BM), 
a larger percentage of T1 B cells would be BrdU  +  , as this 
population would comprise the precursors for additional 
CD21  int   T2 B cells. Animals were fed BrdU continuously via 
the drinking water, and BrdU incorporation was analyzed 
within each splenic B cell subset at the indicated time points. 
On day 1 and 2 after BrdU administration, a signifi  cantly 
higher percentage of CD21  int   T2 cells was BrdU  +   (  Fig. 5, B 
and C  ). However, this ratio reversed on day 4 and 5, with 
more T1 B cells labeled with BrdU. Consistent with previous 
results (  23  ), BrdU labeling was higher in CD23  lo   compared 
with CD23  hi   T1 cells (  Fig. 5 D  ). 
    Figure 3.     CD21  int   T2 B cells develop after T1 B cells.   Kinetic  analysis 
of splenic B cell reconstitution after sublethal irradiation. C57BL/6 mice 
were irradiated with 500 cGy, and splenocytes were analyzed at the indi-
cated time points. Shown is the mean of absolute numbers of each B cell 
subset with SD from three animals. Representative of three indepen-
dent experiments.   
    Figure 4.     CD21  int   T2 B cells contain precursors for both FM and 
T2-MZP/MZ B cells.  CD21 int   T2 B cells were purifi  ed from sublethally 
irradiated mice, labeled with CFSE, and 1  –  2   ×   10  6   cells/recipient  were 
transferred into Ly5.2  +   C57BL/6 mice. Recipient animals were killed at day 
1 or 2 after transfer, and splenocytes were analyzed by staining with the 
indicated markers. (A) After initial gating of host B220  + CD19 +   B  cells, 
splenic B cell subsets were identifi  ed as in   Fig. 1   (left); and T2-MZP/MZ 
were additionally characterized as IgM  hi CD21 hi   cells (right). (B, left) Donor 
cells identifi  ed as Ly5.1  + CFSE +  . (middle and right) Donor B cell subsets 
determined based on gating shown in A. (C) Donor and recipient FM and 
T2-MZP/MZ B cells were compared for relative expression of CD1d. Data 
shown are representative of three experiments with two mice per day for 
each experiment.     160 HOMEOSTATIC PROLIFERATION IN TRANSITIONAL B CELLS | Meyer-Bahlburg et al.
rearrangement, to determine the in vivo replication history 
of B cells (  28  ). Therefore, we used this method to indepen-
dently verify that GFP        CD21  int   T2 B cells have undergone 
the strong proliferative response to TLR signals (  Fig. 6, C 
and D  ). Although the mitogenic responses of GFP        CD21  int   
T2 cells were nearly identical to that observed for T2-MZP 
B cells (  Fig. 2 A  ) (  27  ), this subset exhibited no evidence of 
increased Notch2 signaling (  Fig. 6 E  ). 
  A recent study has used     -deleting recombination exci-
sion circles (KRECs), which are generated during light chain 
    Figure 5.     CD21  int   T2 B cells cycle in vivo.   (A) Cell cycle analysis. Total 
splenocytes from BALB/c mice were stained for B220, IgM, CD21, and 
CD24, and then fi  xed and stained with DAPI and Pyronin Y. After doublet 
exclusion, B220  +   cells were identifi  ed as T1, CD21  int   T2, or FM B cells, and 
the percentage of cells within each phase of cell cycle was determined. 
Data are shown as the mean with SD of fi  ve independent experiments. 
(B  –  D) BrdU labeling of splenic B cell subsets. (B) Representative FACS 
histogram of BrdU labeling in splenic B cells 1 d after continuous BrdU 
administration. (C and D) Percentage of BrdU  +   cells in splenic B cell sub-
sets (C) and CD23  lo   versus  CD23 hi   T1 and CD21  int   T2 B cells (D) over time 
after continuous BrdU administration. *, P   <   0.05; **, P   <   0.01 for CD21  int  
T2 compared with T1 or CD23  lo   T1 cells. Data are representative of two 
independent experiments, and the mean with SD of three mice per time 
point is shown.     
    Figure 6.     Cycling CD21  int   T2 B cells are GFP           .   (A) Cell cycle status of 
GFP  +   versus  GFP       CD21 int   T2 B cells. Data are the mean with SD from 
three independent experiments showing the percentage of CD21  int   T2  B 
cells within each phase of the cell cycle. (B) GFP expression in CD21  int   T2  B 
cells at distinct phases of cell cycle. CD21  int   T2 B cells from Rag2p-GFP Tg 
mice were identifi  ed, and relative GFP expression was determined for each 
phase of the cell cycle. (C) CFSE dilution of GFP  +   versus  GFP       CD21 int   T2 
cells in response to BCR engagement. CFSE-labeled CD21  int   T2 B cells were 
cultured in media alone (dashed lines) or anti-IgM (black lines) for 48 h, 
and proliferation was determined by dilution of CFSE. Numbers shown 
indicate the percentage of live cells under each condition. (D) Mitogenic 
responses of GFP  +   versus  GFP       CD21 int   T2 B cells. Sorted splenic B cell 
subsets were cultured in media alone, with anti-IgM, or with LPS, and 
proliferation was determined. (E) Expression of Notch target genes. 
Splenic B cell subsets were sorted from Rag2p-GFP Tg mice, and the tran-
script levels of Deltex1 and Hes1 was determined. Displayed as fold 
change in expression relative to FM B cells set as 1. All data shown are 
representative of at least three separate experiments.     JEM VOL. 205, January 21, 2008 
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cell divisions in vivo  .   The   Δ  C  T   between genomic coding 
joints and the signal joint of KRECs (equivalent to the num-
ber of cell divisions) in GFP        CD21  int   T2 cells was compara-
ble to T2-MZP/MZ cells, which were previously shown to 
have undergone several cell divisions (  Fig. 7 A  ) (  28  ).   In con-
trast, T1, FM, or GFP  +   CD21  int   T2 B cells had undergone 
only 1  –  2 cell divisions. 
  CD21  int   T2 B cells cycle preferentially in response 
to homeostatic signals 
  Although one key characteristic of CD21  int   T2 B cells was 
their capacity to proliferate in vivo, it remained unclear which 
environmental factors infl  uence proliferation. In our transfer 
experiments using nonlymphopenic hosts, we observed min-
imal proliferation for up to 7 d after transfer (unpublished data). 
This fi  nding was in accordance with published data, indicat-
ing that lymphopenia is the major stimulus for B cell homeo-
static proliferation (HP) (  29  ). Thus, we used recipient B cell  – 
defi  cient   μ  MT mice to compare the capacity of diff  erent B 
cell subsets to respond to signals inducing HP. 
  Purifi  ed Ly5.1  +   T1 cells were labeled with CFSE and 
transferred into unmanipulated   μ  MT mice (Ly5.2  +  ) along 
with   “  feeder  ”   B cells to partially blunt homeostatic signals (  30  ). 
Splenocytes were isolated on day 2, 4, or 7 after transfer and 
evaluated for surface phenotype and relative proliferation by 
dilution of CFSE (  Fig. 8 A  ).   Among recovered splenic B cells, 
1.5  –  2.5% were Ly5.1  +   (derived from transferred T1 cells). 
The percentage of T1 cells at each of these time points was 
negligible (  <  0.5%), and, accordingly, this subset is not shown 
in the data presented. Within 2 d,     7% of labeled B cells had 
proliferated, and this proportion increased progressively to 
62% by day 7. Consistent with this kinetic, CD21  int   T2 cells 
had begun to proliferate at day 2, and nearly all cells within 
this gate proliferated within 7 d. We also identifi  ed transferred 
cells with a T2-MZP/MZ or FM B cell phenotype that had 
proliferated, albeit at a much lower percentage. These obser-
vations indicate that CD21  int   T2 B cells preferentially cycle in 
a lymphopenic environment. 
  Next, we transferred purifi   ed, CFSE-labeled, Ly5.1  +   
CD21  int   T2 B cells (sorted from sublethally irradiated mice) 
into Ly5.2  +     μ  MT mice together with   “  feeder  ”   B cells to di-
    Figure 7.     GFP            CD21  int  T2 have undergone several cell divisions. 
  B cell subsets were sorted from Rag2p-GFP transgenic mice. The number 
of cell divisions, based on the   Δ  C  T   between the coding joint of rearranged 
genomic DNA and signal joint of KRECs formed during IRS-to-RS rear-
rangement in the     -chain locus was determined by real-time PCR. Mean 
with SD from two independent experiments.     
rectly assess the CD21  int   T2 B cell response to homeostatic 
signals. Transferred cells markedly proliferated, with 55% 
having divided by day 3, and     65% having divided by day 5 
and 7 after transfer (  Fig. 8 B  ). Similar to transfer experiments 
in B cell  –  suffi   cient hosts, CD21  int   T2 B cells developed into 
both FM and T2-MZP/MZ B cells. Analysis of various sub-
sets demonstrated that CD21  int   T2 B cells proliferated to the 
greatest extent, followed by T2-MZP/MZ cells, suggesting 
that CD21  int   T2 B cell proliferation precedes that within the 
MZ pool. In contrast, newly formed FM B cells exhibited 
minimal proliferation. Transferred CD21  int   T2 B cells also 
proliferated at earlier time points in comparison to cells de-
rived from T1 B cells (  Fig. 8, A and B  ), suggesting a require-
ment for T1 cell diff  erentiation before active proliferation. 
  We also transferred GFP        FM B cells from Rag2p-GFP 
transgenic mice into     MT mice to determine whether FM B 
cells might give rise to proliferating cells with a CD21  int   T2 
cell phenotype. Transferred FM B cells proliferated (30  –  40% 
on day 7 after transfer), albeit signifi  cantly less extensively than 
transferred CD21  int   T2 B cells (  Fig. 8, B and C  ). However, 
although we clearly identifi  ed T2-MZP/MZ B cells (    60  –
  80%) derived from the input FM population, no donor cells 
acquired a CD21  int   T2 B cell phenotype (  <  1%). Thus, although 
FM B cells can cycle in response to homeostatic signals, cy-
cling CD21  int   T2 B cells are generated at an earlier develop-
mental stage. These fi  ndings indicate that GFP        CD21  int   T2 
cells are not derived from FM B cells, which is consistent with 
our interpretation that GFP  +   and GFP        CD21  int   T2 cells rep-
resent closely related precursors of mature B cells. 
  Collectively, these results indicate that the CD21  int   T2 
B cell subset is poised to respond to homeostatic signals. How-
ever, although proliferation could accompany diff  erentiation, 
it is not required for generation of the mature B cell pool. 
These additional transfer studies also support the hypothesis 
that CD21  int   T2 B cells develop from T1 B cells, and subse-
quently give rise to both FM and T2-MZP/MZ B cells. 
  BAFF inhibition limits B cell HP 
  We next sought to identify stimuli that could induce HP of 
CD21  int   T2 B cells. Among candidate growth factors, avail-
able data strongly implicate BAFF in splenic B cell survival 
and homeostasis (  31, 32  ). Recent data also indicate that B cell 
defi  ciency leads to elevated plasma levels of BAFF (  18  ). We 
therefore determined whether partial blocking of BAFF in B 
cell  –  defi  cient mice would alter the proliferative response of 
CD21  int   T2 B cells. 
  To test this idea, we used an adenovirus vector encod-
ing for TACI-Fc (TACI-Ad), which was previously demon-
strated to block BAFF activity in vivo (  33  ). Recipient   μ  MT 
mice were injected i.v. with TACI-Ad or a control GFP vector, 
GFP-Ad. 7 d later, we adoptively transferred CFSE-labeled 
splenic B cells, and proliferation of transferred cells was ana-
lyzed at day 5 after transfer (  Fig. 9 A  ).   B cells in TACI-Ad  –  in-
fected recipients exhibited lower expression of CD21, which 
is a direct target of BAFF signaling (  34  ), and reduced numbers 
of CD21  hi  CD1d  hi   T2-MZP/MZ B cells (Fig. S5, available at 162 HOMEOSTATIC PROLIFERATION IN TRANSITIONAL B CELLS | Meyer-Bahlburg et al.
refl  ect a greater capacity to compete for available BAFF. To 
address this idea, we analyzed BAFF-R expression in CD21  int   
T2 versus other B cell subsets; and, specifi  cally, within cy-
cling versus noncycling CD21  int   T2 B cells. Bulk CD21  int   T2 
cells had higher BAFF-R levels than either T1 or FM B cells. 
Strikingly, GFP        CD21  int   T2 cells expressed the highest BAFF-
R levels among all subsets (  Fig. 9 B  ). Further, relative BAFF-R 
expression was greater in CD21  int   T2 B cells in G1-G2 versus 
http://www.jem.org/cgi/content/full/jem.20071088/DC1). 
BAFF inhibition also signifi  cantly reduced the number of prolif-
erating B cells (  Fig. 9 A  ), which is consistent with unpublished 
observations cited in a recent review (  30  ). Most notably, a 
detailed subset analysis clearly indicated the preferential loss 
of proliferative responses within the CD21  int   T2 population. 
  The reduction in HP after BAFF inhibition suggested 
that preferential cycling of CD21  int   T2 B cells in vivo might 
    Figure 8.     CD21  int   T2 B cells cycle preferentially in response to homeostatic signals.   (A  –  C) Transfer of T1, CD21  int   T2, or FM B cells into   μ  MT mice. 
1 – 2   ×   10 6   purifi  ed Ly5.1  +   T1 B cells (A), CD21  int   T2 B cells from irradiated mice (B), or GFP        FM B cells (C) were labeled with CFSE and transferred into   μ  MT 
mice together with feeder B cells (13  –  14   ×   10  6   unlabeled  CD43 - Ly5.2 +   splenic B cells/recipient). Recipients were killed on indicated days after transfer, and 
splenocytes were stained as indicated. Gates were set according to cells from a control C57BL/6 mouse. (fi  rst column) Gated analysis of B220  + CD19 +   B 
showing Ly5.1  + CFSE +   donor cells. (second column) Analysis of Ly5.1  + CFSE +   B cell subsets. (third column) CFSE dilution in transferred Ly5.1  +   B cells. (fourth 
column; A and B only) CFSE dilution within each Ly5.1  +   B cell subset. Data from one of two (A and C) or three (B) independent experiments (with two 
mice per time point) are shown.     JEM VOL. 205, January 21, 2008 
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those in G0. This diff  erence was not secondary to cell size, as 
expression of other surface markers remained unaltered (un-
published data). 
  Collectively, these results indicate that CD21  int   T2 B cells 
preferentially cycle in response to homeostatic stimuli, and 
imply that this diff  erential sensitivity is controlled by an en-
hanced capacity to respond to BAFF. 
  Cycling CD21  int   T2 B cells show evidence of antigen-
driven expansion 
  To look specifi  cally for evidence of antigen-driven expansion 
of CD21  int   T2 B cells, we fi  rst determined the relative     - 
versus     -light chain usage among peripheral B cell subsets. 
The majority of immature B cells express a BCR containing 
a     -light chain as opposed to an     -light chain, and the rela-
tive fraction of       +   B cells declines between the immature and 
mature stages, presumably via negative selection (  35, 36  ). 
Consistent with this interpretation, previous work suggests 
that     -light chain expression is enriched on antigen receptors 
exhibiting autoreactivity (  37  ). As anticipated, the     :     ratio 
was increased in the FM versus transitional B cell pool. How-
ever, when we compared GFP  +   versus GFP        CD21  int   T2 B 
cells, we observed the opposite result with a signifi  cant decrease 
in this ratio in the more active GFP        CD21  int   T2 subset (  Fig. 
10 A  ).   Notably, compared with FM B cells, the     :     ratio was 
also lower within the T2-MZP/MZ compartment and con-
sistent with previous reports of selection for self-reactive cells 
within the MZ B cell compartment. 
  To further investigate the apparent skewing of the BCR 
repertoire in the CD21  int   T2 compartment, we used trans-
genic mice expressing the antiphosphorylcholine (anti-PC) 
M167 V  h  1 heavy chain (  38  ). In this strain, B cells expressing 
the PC-binding V  h  1/V       24 heavy/light chain pair are nearly 
undetectable within the BM. In contrast, Id-specifi  c cells are 
signifi  cantly enriched within the MZ compartment, most 
likely through antigen-driven expansion (  14, 38  ). To deter-
mine the point in B cell development at which enrichment 
for PC-binding, V  h  1/V       24-expressing cells is fi  rst apparent, 
we stained peripheral B cell subsets with anti-Id antibodies. 
We observed a signifi  cant increase in Id-specifi  c, CD21  int   T2 
B cells compared with T1 cells (5  –  10% vs.   <  1%;   Fig. 10, B 
and C  ). Id-specifi  c cells were further enriched within the 
MZ B cell population (15  –  20%), whereas the FM subset exhib-
ited little change relative to T1 B cells. Although Id-specifi  c 
CD21  int   T2 B cells were phenotypically indistinguishable 
from non  –  Id-specifi  c cells (unpublished data), a much greater 
percentage of Id-specifi   c cells had progressed beyond G0 
(  Fig. 10 D  ). Together, these data strongly suggest that low-
affi   nity self-antigen stimulation can promote the expansion of 
antigen-specifi  c CD21  int   T2 B cells, and functions in concert 
with other environmental cues to facilitate recruitment into 
the MZ compartment. 
    DISCUSSION   
  Although microenvironmental-mediated selection is clearly 
operative within the transitional B cell compartment, the precise 
subsets that serve as targets for selection remain incompletely 
defi  ned and are the subject of continued controversy. Herein, 
we defi  ne a transitional population that, in contrast to T1 B 
cells, exhibits augmented responses to a range of potential 
microenvironmental stimuli and shows evidence of antigen-
driven expansion. 
  CD21  int   T2 B cells can be distinguished both functionally 
and phenotypically from other splenic B cell developmental 
populations. High expression of GFP (in Rag2p-GFP trans-
genic mice) defi  nitively establishes CD21  int   T2 B cells as an 
immature transitional population. However, in contrast to 
early transitional B cells, these cells are larger, express higher 
levels of IgD and CD62L, and exhibit a signifi  cantly blunted 
apoptotic response after BCR engagement. CD21  int   T2 B 
cells display a rapid proliferative response to LPS stimulation 
that, among splenic B cell subsets, is characteristic of cells 
committed to the MZ B cell lineage. Low expression of the 
Notch target genes, however, defi  nitively distinguishes these 
cells from the T2-MZP developmental subset. CD21  int   T2 B 
cells cycle in vivo, and the actively cycling pool exhibits further 
augmentation in the capacity to respond to BCR engagement 
and/or costimulatory signals. Cycling CD21  int   T2 B cells ex-
press the highest levels of BAFF-R among all peripheral B cell 
    Figure 9.     BAFF signals contribute to CD21  int   T2 B cell HP.   (A)  Effect 
of BAFF inhibition on HP.   μ  MT mice were treated with TACI- or control 
GFP-adenovirus 7 d before transfer of CFSE-labeled splenic B cells (20   ×   
10  6   CD43 -   Ly5.1 +   cells/recipient). Mice were killed 5 d after transfer, and 
splenocytes were surface stained. Ly5.1  +   transferred cells (left) were ana-
lyzed for dilution of CFSE (right). (B) BAFF-R expression. Total splenic B 
cells from Rag2p-GFP Tg mice were stained for B220, IgM, CD24, and 
CD21 and BAFF-R, and BAFF-R expression was compared between B cell 
subsets (left) or in CD21  int   T2 cells at each phase of cell cycle (right). Rep-
resentative of more than fi  ve experiments.     164 HOMEOSTATIC PROLIFERATION IN TRANSITIONAL B CELLS | Meyer-Bahlburg et al.
  Loder et al. initially defi  ned splenic CD21  lo  IgM  hi  IgD  lo-
  CD24  hi   T1 B cells as the key target for negative selection. 
Cells that survived this checkpoint became CD21  int/hi  IgM  hi 
IgD  hi  CD24  hi   T2 B cells, and the authors proposed that an 
antigen-driven selection was required for the subsequent 
development of this population into either mature naive FM 
or MZ B cells (  19  ). 
  In contrast to the aforementioned model, Allman et al. 
described an alternative developmental schema in which three 
nonproliferative transitional subsets (termed T1-T3) were 
identifi  ed based on relative expression of the cell surface 
markers AA4.1, CD23, and IgM. These developmental sub-
sets exhibited a rapid cell turnover rate (which is consistent 
with a transitional stage) and no capacity to enter into the cell 
cycle upon BCR stimulation, but they exhibited a progres-
sive increase in their responsiveness to CD40 and TLR stim-
ulation (  23, 42, 44  ). 
  Subsequent studies have only partially resolved the diff  er-
ences within these developmental models. It is now clear that 
the CD24  hi  CD21  int/hi   late transitional population described 
by Loder et al. is both functionally and developmentally het-
erogeneous (  19  ). Mice lacking expression of the NF    B p50 
subunit or the Notch2 receptor exhibit a selective loss of 
both MZ B cells and CD24  hi  CD21  hi   splenic B cells (  21, 45  ). 
Based on these fi  ndings, Pillai et al. suggested that the CD-
24  hi  CD21  hi   T2 population is predominantly comprised of 
MZ-restricted progenitors (  46  ). Consistent with this sugges-
tion, Srivastava et al. showed that CD21  hi   T2 cells comprise 
a long-lived, self-renewing compartment, and that develop-
ment of FM B cells in sublethally irradiated animals precedes 
generation of this subset (  22  ). 
  In contrast to CD21  hi   T2 cells, the CD21  int   T2 subset, as 
experimentally defi  ned here, comprises a bipotent transitional 
population. Kinetic analysis of the peripheral B cell compart-
ment after sublethal irradiation or after adoptive transfer of 
T1 cells into adult recipients demonstrates that CD21  int   T2 
cells are most likely derived from less mature splenic T1 
(CD24  hi  CD21  lo  ) progenitors. However, it might be possible 
that some splenic CD21  int   T2 cells derive from early transi-
tional cells in the BM, as two recent publications have shown 
that transitional cells can also develop in the BM and exit into 
the periphery (  36, 47  ). Independent of where this develop-
ment occurs, analysis of GFP expression (in Rag2p-GFP Tg 
mice) indicates that CD21  int   B cells are newly derived (within 
2  –  4 d, based on the half-life of GFP) from BM precursor B 
cells, and, in contrast to CD21  hi   T2-MZP subset, do not com-
prise a long-lived population. In addition, the Notch pathway 
is minimally active in CD21  int   T2 cells, and it is subsequently 
up-regulated in T2-MZP and MZ B cells. Finally, using 
adoptive transfer experiments in normal and lymphopenic 
recipients, we clearly show that CD21  int   T2 B cells include 
the immediate precursors for both FM and MZ B cells. 
  Our fi  ndings also fi  rmly establish that environmental cues 
can promote the proliferation of a subpopulation of cells within 
the CD21  int   T2 B cell compartment. The question as to whether 
transitional B cells cycle has been a subject of controversy. 
subsets, and BAFF mediates HP of this subset in vivo  .   Cy-
cling CD21  int   T2 B cells are partially enriched for       +   cells, 
and M167 BCR Id-specifi  c B cells are fi  rst selected within 
the cycling CD21  int   T2 population, suggesting that specifi  c 
BCR ligands may promote amplifi  cation of this subpopulation. 
  The observation that B cells enter the periphery as imma-
ture B cells arising from the BM was fi  rst published by Allman 
et al. (  39, 40  ). The term transitional B cell was subsequently 
introduced by Carsetti et al. describing recently migrated im-
mature splenic B cells in transition from the immature to the 
mature B cell compartments and a target of BCR-mediated 
selection (  41  ). Although alternative criteria have been pro-
posed (  20, 42  ), the Loder (  19  ) and Allman (  23  ) schema are 
now widely used by a range of investigators to characterize 
splenic transitional B cells in various experimental contexts 
anticipated to impact peripheral B cell function. However, 
although these schemas use a similar nomenclature, they refer 
to discordant late transitional B cell populations (  43  ) and, to 
a large degree, have implicated alternative events in shaping 
the mature B cell repertoire. 
    Figure 10.     CD21  int   T2 cells show evidence of antigen-mediated 
selection.   (A) BCR     + /   +   ratio. The percentage of     +   versus     +   B  cells 
within each B cell subset in wt mice was determined by FACS and dis-
played as the ratio of     + /   +   B cells. Mean of four mice with SD is shown. 
(B and C) Determination of percentage of Id-specifi  c cells within each B 
cell subset in M167 transgenic mice. (B) Representative histograms from 
one M167 transgenic and wt animal. (C) Average of Id-specifi  c cells with 
SD from four mice in two independent experiments. (D) Cell cycle status 
of Id-specifi  c cells. Total splenocytes were stained as in   Fig. 5 A  , with the 
addition of the anti-Id antibody. Shown is the percentage of Id-specifi  c 
cells in G0 or G1 within the CD21  int   T2  population.   JEM VOL. 205, January 21, 2008 
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strong BAFF signals (  17, 18  ), and data from both humans and 
mice indicate that these selective forces operate at the transi-
tional stage (  6, 54  ). Whether autoreactive B cells can be spe-
cifi  cally expanded within the transitional B cell pool, however, 
represents a crucial unanswered question. Using the M167 
BCR heavy chain transgenic mouse, we observed a marked 
expansion of PC-binding B cells within the CD21  int   T2 com-
partment. Further, our data demonstrate that this Id-specifi  c 
CD21  int   T2 B cell population is signifi  cantly enriched for cy-
cling cells. In addition, we also identifi  ed a clear increase in 
the relative percentage of       +   cells specifi  cally within the cy-
cling CD21  int   T2 B cell population. This enrichment con-
trasts with the progressive decline in       +   cells observed across 
other sequential peripheral B cell subsets, as shown here and 
as previously described (  36  ). Collectively, these observations 
strongly imply that cells expressing a self-reactive BCR can 
be specifi  cally amplifi  ed with the CD21  int   T2 B cell subset. 
  Although proliferation or antigen-driven expansion of 
CD21  int   T2 cells is clearly not required for the generation of 
mature B cells, our combined data support a model in which 
antigen encounter (in concert with environmental cues includ-
ing BAFF) can promote the competitive expansion of cells 
within this compartment. According to the measurement 
of KRECs, CD21  int   T2 cells and T2-MZP/MZ cells have 
undergone a similar number of cell divisions. However, our 
BrdU studies suggest that this cell division occurs prefer-
entially at the CD21  int   T2 stage. These combined fi  ndings 
imply that CD21  int   T2 cells, upon receiving the appropriate 
signals, begin to divide and are preferentially driven into a 
MZ B cell fate. Because BCR engagement positively modu-
lates BAFF-R expression (  16  ), our fi  ndings also suggest that 
BCR signaling coordinately amplifi  es BAFF-independent 
and -dependent signals within the cycling CD21  int   T2 sub-
population. This selection program appears to be enhanced 
in conditions leading to high BAFF levels, as experimentally 
implied in our adoptive transfer and BAFF inhibition experi-
ments. Accordingly, in BAFF transgenic mice, autoreactive 
cells are primarily found within the MZ (  48  ) and high BAFF 
levels in humans promote autoimmune diseases, including 
Sjogren  ’  s syndrome (  55  ). 
  Finally, in light of the developmental capacity of the 
CD21  int   T2 B cell subset, it remains possible that antigen-ex-
panded cells might also develop into FM B cells. Although it 
is not addressed in this study, such a scenario might be opera-
tive in selected autoimmune-prone genetic contexts. Identi-
fi  cation of a transitional population where self-reactive B cells 
are initially expanded sets the stage for a range of future stud-
ies investigating the selective forces operative at this key point 
in peripheral B cell development. 
    MATERIALS AND METHODS   
  Mice.     BALB/c, C57BL/6 (Ly5.1 and Ly5.2),   μ  MT, and Rag2p-GFP mice 
were bred and maintained in the specifi  c pathogen  –  free animal facility of the 
Children  ’  s Hospital and Regional Medical Center (Seattle, WA) and han-
dled according to Institutional Animal Care and Use Committee ap-
proved protocols. Notch2 haplodefi  cient mice were provided by T. Gridley 
T2 B cells were originally described as being comprised of 
a large percentage of cycling cells (  19  ). This view is supported 
by a recent study indicating that    8% of B220  +  AA4.1  +  CD24  hi   
B cells are in the S/G2 phase (  48  ), and by studies demonstrat-
ing a proportion of Ki-67  +   cells within the transitional B cell 
compartment in human peripheral blood (  49  ). In contrast, 
Allman et al. have consistently reported that transitional B cells 
do not contain signifi  cant numbers of cycling cells (  22, 23  ), 
and this conclusion has been supported by others using simi-
lar gating criteria (  44  ). We used several alternative approaches 
to determine whether CD21  int   T2 B cells are cycling within 
the spleen, including DAPI/Pyronin Y staining, measurement 
of KRECs in splenic B cell subsets, and short-term in vivo 
BrdU-labeling kinetics. Our combined data from these analyses 
clearly indicate that a small but consistent fraction of CD21  int   
T2 B cells is cycling in vivo. 
  Diff  erences between our data and previously published 
cell cycle analyses may be caused, in part, by alternative cell 
gating strategies. Using the Allman transitional B cell gating 
schema and seven-color fl  ow cytometry, cycling CD21  int   T2 
cells fall within each of the T1  –  T3 subsets, and because of the 
relatively small size of this population they are nearly unde-
tectable (Fig. S6, available at http://www.jem.org/cgi/con-
tent/full/jem.20071088/DC1). In contrast, gating as shown 
in   Fig. 1   readily identifi  es cycling cells. This latter observa-
tion additionally strengthens our interpretation that CD21  int   
T2 B cells comprise a distinct, late transitional subset. 
  Our observations partially defi  ne the signals that mediate 
cycling within the late transitional B cell compartment. When 
transferred into a B cell  –  suffi   cient host, CD21  int   T2 B cells 
proliferate very little, although they develop into both FM 
and T2-MZP/MZ B cells, indicating that cycling is not a 
prerequisite for entering the mature B cell pool. In contrast, 
as shown here and as previously described (  30, 50  ), both ma-
ture and transitional B cells proliferate when introduced into 
a lymphopenic environment, a process termed HP. Because 
B cell defi  ciency leads to increased levels of BAFF in both 
humans and mice (  18, 51  ), we hypothesized that BAFF sig-
nals are involved in HP. Although B cells do not proliferate 
in response to BAFF in vitro, BAFF can induce entry into 
early G1 (  52  ). Moreover, stimulation with BAFF leads to an 
increase in cell size and glucose metabolism (  31  ), up-regula-
tion of Ki-67, Cyclin D2, and Cdk4 expression, and phos-
phorylation of RB and Akt (  53  ). These fi  ndings, combined 
with our experimental data, strongly suggest that in vivo, 
BAFF is critical for cycling of CD21  int   T2 B cells. Consistent 
with this model, inhibition of BAFF markedly attenuated the 
cycling of CD21  int   T2 cells in     MT hosts, and CD21  int   T2 B 
cells in G1 and beyond expressed the highest levels of BAFF-
R, fi  ndings that directly correlated with preferential prolifer-
ative responses in lymphopenic hosts. 
  There is mounting evidence that alterations in transitional 
B cell homeostasis mediated by BAFF can signifi  cantly im-
pact the mature BCR repertoire (  30, 32, 54  ). Under normal 
physiological conditions, B cells directly compete for avail-
able BAFF (  18, 54  ), autoreactive B cells can be rescued by 166 HOMEOSTATIC PROLIFERATION IN TRANSITIONAL B CELLS | Meyer-Bahlburg et al.
(Jackson ImmunoResearch Laboratories). M167 heavy chain transgenic mice 
(M167H Tg mice, line U243-4) were provided by J. Kenny and A. Lustig 
(National Institute of Aging, Bethesda, MD) and established as a M167H 
Tg/Tg homozygous breeding colony in the animal facility of the Albert 
Einstein College of Medicine. Mice used in all experiments were between 
6 and 16 wk of age. 
  Reagents and antibodies.     Antibodies used in this study included reagents 
specifi   c for the following: active-caspase 3 (C92-605), CD24 (M1/69), 
CD21 (7G6), B220 (RA3-6B2), and CD1d (1B1; BD Biosciences); CD23 
(B3B4; Invitrogen); Ly5.1 (A20), Ly5.2 (RA3-6B2), AA4.1, and CD62L 
(MEL-14; eBioscience); IgD (11-26),     -LC (187.1),     -LC (JC5-1), and IgM 
(1B4B1; SouthernBiotech); CD19 (ID3; BioLegend); and BAFF-R (204406; 
R  &  D Systems). Polyclonal F(ab  ’  )  2   anti-IgM for BCR stimulation and non-
stimulatory Fab anti-IgM for cell sorting were purchased from Jackson 
ImmunoResearch Laboratories. Antiidiotypic M167 (28-5-15) was produced 
from a hybridoma line provided by J. Kenny and A. Lustig, and it was puri-
fi  ed and conjugated with Alexa Fluor 647 using standard methods. Addi-
tional reagents included the following: 7-amino actinomycin D (7-AAD), 
Pyronin Y, and DAPI (Invitrogen); LPS (Sigma-Aldrich); anti-CD40 (a gift 
from G. Cheng, University of California Los Angeles, Los Angeles, CA); and 
recombinant mouse BAFF (Thermo Fisher Scientifi  c). 
  Flow cytometry and cell sorting.     Single-cell suspensions from BM and 
spleen were incubated with fl  uorescently labeled antibodies for 30 min at 
4  °  C in staining buff  er (PBS with 0.5% BSA or 2.5% FCS). Data were col-
lected on a FACSCalibur or LSR II fl  ow cytometer (BD Biosciences) and 
analyzed using FlowJo software (Tree Star, Inc.). Overlays of histogram are 
shown using the off  set mode in FlowJo. For LSR II experiments, the data 
were analyzed using biexponential transformation function for complete data 
visualization. For caspase 3 assays, cells were surface stained, fi  xed, and per-
meabilized per manufacturer  ’  s instructions, and incubated with anti  –  active 
caspase 3 for 45 min at room temperature. 7-AAD was used to diff  erentiate 
between dead and live cells. For cell cycle analysis, cells were surface stained, 
fi  xed overnight with 2% PFA, washed, and incubated for 30 min with 1     g/
ml DAPI in PBS with 0.1% BSA and 0.1% Triton X-100. 1.5     g/ml Pyro-
nin Y was added immediately before analysis. 
  For cell sorting, CD43 depletion was performed using magnetic bead  –
  conjugated anti-CD43 antibodies according to the manufacturer  ’  s instruc-
tions (Miltenyi Biotech), and enriched cells were labeled with specifi  c 
antibodies in staining buff  er. Sorting was performed using a FACSAria sorter 
with FACSDiva software (BD Biosciences). 
  Cell culture and proliferation assays.     Purifi  ed cells were cultured in 
complete media (RPMI 1640 with 10% FCS, 4     M   l-  glutamine, 50     M 
2-ME, 10 mM Hepes, and antibiotics) at 37  °  C. Cells were stimulated with 
10     g/ml polyclonal goat F(ab  ’  )  2   fragment anti  –  mouse IgM, 1   μ  g/ml anti  –
  mouse CD40, 10   μ  g/ml LPS, or 50 ng/ml BAFF; incubated in triplicate 
(5   ×   10  4   cells/well) for 48 h; pulsed with 1     Ci [  3  H]thymidine for 8 h before 
harvesting, and analyzed using a scintillation counter. 
  Real-time PCR.     Sorted B cell populations were pelleted and frozen at 
  –  80  °  C. RNA was isolated using the RNeasy Micro kit (QIAGEN) and 
converted into cDNA by reverse transcription (Superscript II; Invitrogen) 
according to the manufacturer  ’  s instructions. Real-time PCR on cDNA 
was performed using the iCycler real-time PCR detection system with IQ 
SYBR Green Supermix (Bio-Rad Laboratories) according to the manufac-
turer  ’  s instructions. Ratios were calculated using the Pfaffl     ’  s mathematical 
model for relative quantifi  cation  (  56  ), with mouse     2-microglobulin as 
housekeeping control. All real-time PCR analysis shown includes at least 
three independent experiments. Primer sequences used include the fol-
lowing: Hes1-5    GAGAAGAGGCGAAGGGCAAGAAT; Hes1-3     GAG-
GTGCTTCACAGTCA; Deltex1-5     CGGACATTTGAGACCCACTT; 
Deltex1-3     CCACTTTCAAGCAGGGAGAA; CyclinD2-5     GCCAA-
GATCACCCACACT; and CyclinD2-3     GCTGCTCTTGACGGAACT. 
To determine the replication history of B cells, genomic DNA was isolated 
from sorted populations and the ratio between the     -deleting rearrangement 
(IRS1 to RS) and excision circles (KREC) was determined by TaqMan-
based (Applied Biosystems) real-time PCR, as previously described (  28  ). 
  BrdU incorporation.     Continuous in vivo BrdU labeling was performed 
by feeding mice BrdU via the drinking water containing 1   μ  g/ml BrdU 
(Sigma-Aldrich) and 10% sucrose. Mice were killed at indicated time points, 
and splenocytes were surface stained to identify splenic B cell subsets. Cells 
were then fi  xed and permeabilized, treated with DNase, and stained with 
anti-BrdU FITC (BrdU kit from BD Biosciences). 
  Adoptive cell transfer.     CD43-depleted B cells or sorted B cell subsets 
were incubated with 0.05     M CFSE at 37  °  C for 8 min, washed three times 
with complete media, and then washed with PBS. In experiments using 
  “  feeder  ”   B cells, CD43-depleted splenic B cells were prepared and mixed 
with sorted B cells. For transfer of sorted T1 or CD21  int   T2 B cells, a total 
number of 15   ×   10  6   cells in 250   μ  l PBS were injected by tail vein into   μ  MT 
or C57BL/6 mice. 
  In vivo inhibition of BAFF.     TACI- or control GFP-adenovirus (pro-
vided by R. Carter, University of Alabama, Tuscaloosa, AL) were prepared 
as previously described (  33  ) and injected into the tail vein at 10  9   PFU per re-
cipient, followed 6  –  7 d later by transfer of 20   ×   10  6   CD43-depleted, CFSE-
labeled splenic B cells (Ly5.1  +  ). Mice were killed 5 d after adoptive transfer, 
and splenocytes were stained for B220, CD19, CD24, CD21, CD1d, IgM, 
and Ly5.1. 
  Online supplemental material.     Fig. S1 shows sorting gates and postsort 
purities. Fig. S2 shows the phenotypic and functional properties of CD21  int   
T2 cells from irradiated mice. Fig. S3 shows how cell cycle subsets are gated. 
Fig. S4 shows surface markers on GFP  +   versus GFP        CD21  int   T2 cells. Fig. 
S5 compares the expression of cell surface markers on B cells from control 
versus TACI-Ad  –  treated mice. Fig. S6 compares transitional subsets, as gated 
by Allman et al., and CD21  int   T2 B cells. Table S1 summarizes the expres-
sion of cell surface markers on peripheral B cell subsets described in this 
work. The online version of this article is available at http://www.jem
.org/cgi/content/full/jem.20071088/DC1. 
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